These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 33800954)

  • 21. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system.
    Wang P; Jin L; Zhang M; Wu Y; Duan Z; Guo Y; Wang C; Guo Y; Chen W; Liao Z; Wang Y; Lai R; Lee LP; Qin J
    Nat Biomed Eng; 2024 Aug; 8(8):1053-1068. PubMed ID: 37349391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein.
    Suprewicz Ł; Fiedoruk K; Czarnowska A; Sadowski M; Strzelecka A; Galie PA; Janmey PA; Kułakowska A; Bucki R
    Neurol Neurochir Pol; 2023; 57(1):14-25. PubMed ID: 36810757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
    Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
    Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
    Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
    J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells.
    Bleau C; Filliol A; Samson M; Lamontagne L
    J Virol; 2015 Oct; 89(19):9896-908. PubMed ID: 26202229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological Symptoms of COVID-19: The Zonulin Hypothesis.
    Llorens S; Nava E; Muñoz-López M; Sánchez-Larsen Á; Segura T
    Front Immunol; 2021; 12():665300. PubMed ID: 33981312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
    Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
    Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Mechanisms of COVID-19-Sleep Disorders.
    Semyachkina-Glushkovskaya O; Mamedova A; Vinnik V; Klimova M; Saranceva E; Ageev V; Yu T; Zhu D; Penzel T; Kurths J
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids.
    Pellegrini L; Albecka A; Mallery DL; Kellner MJ; Paul D; Carter AP; James LC; Lancaster MA
    Cell Stem Cell; 2020 Dec; 27(6):951-961.e5. PubMed ID: 33113348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
    Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
    Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
    Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
    Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection.
    Trevino TN; Almousawi AA; Robinson KF; Fogel AB; Class J; Minshall RD; Tai LM; Richner JM; Lutz SE
    J Neuroimmunol; 2024 Mar; 388():578309. PubMed ID: 38335781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
    Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B
    Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
    ElBini Dhouib I
    Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
    Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
    Yang F; Zhao H; Liu H; Wu X; Li Y
    Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.